Romidepsin in Treating Patients With Relapsed Small Cell Lung Cancer

Summary

This phase II trial is studying how well FR901228 works in treating patients with recurrent small cell lung cancer. FR901228 may stop the growth of tumor cells by blocking the enzymes necessary for their growth.

Timeline

Start

2004-05

Primary completion

2006-11

Completion

—

Drugs

Indications